Profound Medical Corp (PRN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,233 | 1,910 | 2,009 | 1,728 | 1,602 |
| Cost of Goods | 795 | 641 | 950 | 668 | 552 |
| Gross Profit | 1,438 | 1,269 | 1,059 | 1,060 | 1,050 |
| Operating Expenses | 9,271 | 8,751 | 9,841 | 7,620 | 7,486 |
| Operating Income | -7,833 | -7,482 | -8,782 | -6,560 | -6,436 |
| Interest Expense | N/A | N/A | N/A | N/A | 192 |
| Other Income | 934 | 1,322 | -356 | 1,014 | -692 |
| Pre-tax Income | -6,899 | -6,160 | -9,138 | -5,546 | -7,320 |
| Income Tax | 20 | 39 | -229 | 18 | 35 |
| Net Income Continuous | -6,919 | -6,199 | -8,909 | -5,564 | -7,355 |
| Net Income | $-6,919 | $-6,199 | $-8,909 | $-5,564 | $-7,355 |
| EPS Basic Total Ops | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |
| EPS Basic Continuous Ops | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |
| EPS Diluted Total Ops | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |
| EPS Diluted Continuous Ops | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |
| EBITDA(a) | $-7,546 | $-7,177 | $-7,794 | $-6,273 | $-6,851 |